PAVmed Inc. Common Stock
PAVMPAVmed Inc. (PAVM) is a medical technology company focused on developing and commercializing innovative healthcare products. The company emphasizes minimally invasive solutions across various medical specialties, including diagnostics, devices, and digital health, aiming to improve patient outcomes and reduce healthcare costs.
Company News
Lucid Diagnostics will host a business update conference call on November 12, 2025, at 8:30 AM ET, where CEO Lishan Aklog will discuss company operations and growth strategy, and CFO Dennis McGrath will review Q3 2025 financial results.
PAVmed Inc. (PAVM) closed at $2.07 in the latest trading session, marking a -1.43% move from the prior day.
Biotech penny stocks for your watch list this week. The post Best Penny Stocks To Buy? 5 Biotech Stocks For Your Watch List This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced a procedural update on its settlement of a previously disclosed class action lawsuit.
News of a fresh round of capital raising seems to be making some investors ill.
